Harvia Oyj (0ABF)
London Exchange · UK · prices in EUR · close of 19 Oct 2026
Key indicators
| Last close | EUR 44.70 |
|---|---|
| 52-week range | 30.99 – 46.90 |
| Return, 1 month / 3 months | +5.7% / +8.8% |
| Return, 1 year / 3 years | +28.1% / +98.9% |
| Trend | Uptrend |
| RSI (14) | 59 |
| Volatility (1 year) | 39.0% |
| Worst drawdown (1 year) | -26.3% |
| Average daily value traded | 0.09M EUR |
| Dividend yield | 2.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Harvia Oyj is a Finnish company that designs and manufactures saunas, sauna heaters and related equipment. Its product range covers electric and wood-burning sauna stoves, complete sauna rooms and accessories, sold under brands such as Harvia and Almost Heaven Saunas. Customers include private households, spa operators, hotels and wellness businesses, and the company also provides installation and maintenance support. Harvia is based in Muurame, Finland, and serves customers in many countries.
The shares are listed on the London Exchange in UK under the code 0ABF, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Harvia Oyj (0ABF) trades on the London Exchange in UK. It last closed at EUR 44.70 on 19 October 2026.
Its price-based Market X-Ray is 62 out of 100 (a fair price profile), ranking 1,148 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 28.1% and over the last three months it rose 8.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 83 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 12.6% | ||
| From 52-week high | -1.1% | ||
| Momentum | 77 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 8.8% | ||
| 6-month return | 26.1% | ||
| 12-month return, skipping the last month | 21.2% | ||
| Stability (higher is calmer) | 50 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 39.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -26.3% | ||
| Liquidity | 29 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.09M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 53 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.6% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +2.3% |
|---|---|
| 1 month | +5.7% |
| 3 months | +8.8% |
| 6 months | +26.1% |
| 1 year | +28.1% |
| 3 years | +98.9% |
| 5 years | – |
Signals
| 50-day / 200-day average | 43.48 / 39.71 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.90 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 16 Oct 2026 | EUR 0.3800 |
| 16 Apr 2026 | EUR 0.3900 |
| 20 Oct 2025 | EUR 0.3700 |
| 9 Apr 2025 | EUR 0.3800 |
| 18 Oct 2024 | EUR 0.3400 |
| 29 Apr 2024 | EUR 0.3400 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.